Industry-Expert Theaters

ACC.17 Media

Connect with the experts in the Industry-Expert Theater as presenters share the latest in cardiovascular practices, services and technologies while you enjoy refreshments or lunch — presentations are conveniently scheduled during the daily breaks.

  Friday, March 17
  Friday, March 17
10:15 a.m. – 11:15 a.m.

Session title to be announced
Theater 1, Expo Hall, #1955
Speakers to be announced
Sponsored by Boehringer Ingelheim
Session title to be announced
Theater 2, Expo Hall, #2255
Speakers to be announced
Sponsored by Amgen

12:45 p.m. – 1:45 p.m.

Session title to be announced
Theater 1, Expo Hall, #1955
Speakers to be announced
Sponsored by Novartis Pharmaceuticals Corporation


Repatha®(evolocumab): A Focused Clinical Review
Theater 2, Expo Hall, #2255

Reduction in circulating levels of low‐density lipoprotein cholesterol (LDL‐C) remains fundamental to major cholesterol treatment guidelines and recommendations from medical organizations.1‐7 This program will review a current therapy for additional LDL-C lowering.

Speakers to be announced
Sponsored by Amgen
3:45 p.m. – 4:45 p.m.

Advancing the Standard of Care for Preventing Sudden Cardiac Death – the Wearable Cardioverter Defibrillator
Theater 1, Expo Hall, #1955
Speakers to be announced
Sponsored by ZOLL
Session title to be announced
Theater 2, Expo Hall, #2255
Speakers to be announced
Sponsored by Relypsa, Inc.

 
  Saturday, March 18
  Saturday, March 18

9:45 a.m. – 10:45 a.m.

Putting Guidelines Into Practice: New Recommendations for Optimal Treatment of Heart Failure With Reduced Ejection Fraction (HFrEF)
Theater 1, Expo Hall, #1955
Speakers to be announced
Sponsored by Novartis Pharmaceuticals Corporation


Repatha®(evolocumab): A Focused Clinical Review
Theater 2, Expo Hall, #2255

Reduction in circulating levels of low‐density lipoprotein cholesterol (LDL‐C) remains fundamental to major cholesterol treatment guidelines and recommendations from medical organizations.1‐7 This program will review a current therapy for additional LDL-C lowering.

Speakers to be announced
Sponsored by Amgen
12:45 p.m. – 1:45 p.m.

Session title to be announced
Theater 1, Expo Hall, #1955
Speakers to be announced
Sponsored by Janssen Pharmaceuticals Inc.
*This session adjourns at 2:00 p.m.
Session title to be announced
Theater 2, Expo Hall, #2255
Speakers to be announced
Sponsored by Amgen

3:45 p.m. – 4:45 p.m.

Session title to be announced
Theater 1, Expo Hall, #1955
Speakers to be announced
Sponsored by Novartis Pharmaceuticals Corporation


New Clinical Trial Data for Jardiance® (empagliflozin) Tablets
Theater 2, Expo Hall, #2255

This program will discuss recent data from the ongoing JARDIANCE clinical development program. The presentation will cover efficacy and safety data, as well as the dosing information for JARDIANCE. Attendees will have the opportunity to ask the faculty questions about the data presented, and refreshments will be provided.

Pam R. Taub, MD, FACC; Associate Professor of Medicine, University of California, San Diego
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA
 
  Sunday, March 19
  Sunday, March 19

9:45 a.m. – 10:45 a.m.

Session title to be announced
Theater 1, Expo Hall, #1955
Speakers to be announced
Sponsored by Novartis Pharmaceuticals Corporation


Session title to be announced
Theater 2, Expo Hall, #2255
Speakers to be announced
Sponsored by Abbott Vascular
11:30 a.m. – 12:30 p.m.

Session title to be announced
Theater 1, Expo Hall, #1955
Speakers to be announced
Sponsored by Pfizer
Session title to be announced
Theater 2, Expo Hall, #2255
Speakers to be announced
Sponsored by Abbott Vascular

Schedule is current as of January 6, 2017, and is subject to change. Please check back for updates.


* Industry-Expert Theater presentations are not part of ACC.17, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Advertisement

ACC Logo
ACC.17 on Social Media:
      
2016 American College of Cardiology Foundation. Visit ACC.org
Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Contact Us